Mea Culpa Retractions

Researchers earn applause after recalling two papers containing misinterpreted findings.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, JEAN-ETIENNE MINH-DUY POIRRIERTypically, retractions signal research misconduct more often than they highlight good science. But a pair of retractions by Jeffrey Kelly's group at The Scripps Research Institute received praise for correcting the record after the researchers discovered their initial conclusions were incorrect. Ivan Oransky wrote at Retraction Watch that “Kelly and his colleagues deserve kudos for their efforts, at their own professional expense, to correct the scientific literature.”

It was while examining amyloid disaggregase activities recently that the researchers realized their years-old mistake. Back in 2009, Kelly’s team was examining disaggregation of cross-β-sheet amyloid (Aβ) fibrils in vitro. What the group had interpreted as disaggregation of the Aβ fibrils at the time actually turned out to be Aβ fibrils sticking to the surfaces of multi-well plates and centrifuge tubes. Kelly told Retraction Watch that it took the team “almost a year of effort to figure this out and convince my trainees who actually did the initial experiments that we misinterpreted our data.”

He and his colleagues published their corrected findings this month in Protein Science. Their now-invalidated findings were published in the same journal a few years ago. In their latest report they ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies